Adam Ang
Also, scientists from the University of South Australia have developed tiny fibre sensors for remote patient monitoring.
Also, CureApp is getting $77 million in investment from the Sawai Group as part of their license deal.
The new funds will be used to support the rollout of its hypertension DTx app.
It is now preparing for a Series A fundraising round in the next six months.
There is a plan to expand its trial to more ambulances in the country to study its effectiveness.
It features more than 1,200 combinations of randomised simulated situations in a hospital ward.
The company also has pending approvals for the device in Australia and Thailand.
The online treatment has been licensed to Blue Note Therapeutics for the development of a counterpart version in North America.
Also, engineers from the University of Hong Kong have come up with a tiny biosensing platform for personalised health monitoring.
It will soon launch its mobile app on Android and iOS devices.